Blutree Orthopedic Implants
Blutree Orthopedic Implants
Engineered to strict clinical quality parameters, satisfying international safety regulations for active implantable and orthopedic treatments.
Founded in 1999, our enterprise stands as one of the pioneer organizations in China committed to the research, development, and high-precision production of implantable orthopedic devices and micro-medical structures. Over the last two decades, we have continuously translated complex biomechanical principles into world-class implant systems.
By leveraging our deep-seated proficiency in titanium micro-milling, biocompatible coatings, and cleanroom assembly, we have transitioned our state-of-the-art capability into the design and production of Neurostimulators (Active Implantable Medical Devices - AIMD). We work closely with clinical developers, academic partners, and global medical device OEMs to engineer neuromodulation devices that address chronic pain, movement disorders, and therapeutic neural interfaces.
How medical science and micro-manufacturing converge to deliver next-generation therapeutic intervention.
Neuromodulation has transitioned from a last-resort intervention to a cornerstone therapy for chronic conditions. Neurostimulators modulate electrical signals in central, peripheral, or autonomic neural pathways to manage:
Developing an active implantable device from scratch demands multi-disciplinary expertise. As a contract manufacturer, we provide turnkey solutions:
Active implants fall under the highest regulatory classification globally (Class III FDA/MDR). Our ISO 13485 facilities feature:
Our in-house capabilities span raw titanium machining to high-level micro-structural finishes, ensuring optimal clinical performance.
As the neuromodulation market shifts toward personalized, closed-loop solutions, we are investing heavily in technologies that define the next decade of therapeutic delivery:
By integrating ultra-compact multi-layer flexible print circuit boards (Flex-PCBs) inside hermetically-sealed micro-titanium cases, we aim to reduce overall device volume by up to 35%, facilitating minimally invasive patient implantation procedures.
Future implant architectures will incorporate local field potential (LFP) feedback. The stimulator dynamically adapts stimulation parameters based on real-time neural activity, reducing battery draw and avoiding target habituation.
Using specialized vacuum magnetron sputtering system configurations, we apply ultra-thin films of Platinum-Iridium (Pt-Ir) and Iridium Oxide (IrOx) to maximize charge injection capacity, ensuring safe stimulation at smaller electrode footprints.
Operating as a premier global OEM exporter involves navigating a complex web of national health mandates and manufacturing protocols. We ensure absolute compliance at every phase:
Addressing technical, material, and regulatory inquiries from design engineers and procurement officers.
Complementary surgical toolsets, specialized fasteners, and equipment engineered to support complex orthopedic and neuromodulation therapies.
